Publication | Closed Access

Synergistic active targeting of dually integrin α v β 3 /CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies

NanomedicineTumor BiologyMouse BodiesIntegrin α VSynergistic Active TargetingTherapeutic NanomaterialsImmunologyNano-drug DeliveryTumor TargetingMedicineCell BiologyCancer Research